FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
Clinical trial NCT04714372 · COMPLETED
Trial details
- NCT number
- NCT04714372
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2024-01-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.